WordNet

write by means of a keyboard with types; "type the acceptance letter, please" (同)typewrite
a small metal block bearing a raised character on one end; produces a printed character when inked and pressed on paper; "he dropped a case of type, so they made him pick them up"
(biology) the taxonomic group whose characteristics are used to define the next higher taxon
a subdivision of a particular kind of thing; "what type of sculpture do you prefer?"
all of the tokens of the same symbol; "the word `element contains five different types of character"
printed characters; "small type is hard to read"
identify as belonging to a certain type; "Such people can practically be typed" (同)typecast
a substance that retards or stops an activity
writing done with a typewriter (同)typewriting

PrepTutorEJDIC

〈C〉(…の)『型』,タイプ,類型,種類(kind)《+of+名》 / 〈C〉(その種類の特質を最もよく表している)『典型』,手本,模範《+of+名》 / 〈U〉《集合的に》活字;〈C〉(1個の)活字 / 〈U〉(印刷された)字体,活字 / 〈C〉(貨幣・メダルなどの)模様,図柄 / 〈C〉血液型(blood group) / …‘を'タイプに打つ / (…として)…‘を'分類する《+名+as+名(doing)》 / …‘の'型を決める / タイプライターを打つ
抑制する人(物) / 化学反応抑制剤

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 男性性機能不全の治療 treatment of male sexual dysfunction
2. 成人における肺高血圧症の治療 treatment of pulmonary hypertension in adults
3. 糖尿病における勃起不全 erectile dysfunction in diabetes mellitus
4. 心疾患患者における性的活動 sexual activity in patients with heart disease
5. 全身性硬化症（強皮症）における肺血管疾患：治療 pulmonary vascular disease in systemic sclerosis scleroderma treatment

English Journal

How to treat erectile dysfunction in men with diabetes: from pathophysiology to treatment.

Hatzimouratidis K1, Hatzichristou D.
Current diabetes reports.Curr Diab Rep.2014 Nov;14(11):545. doi: 10.1007/s11892-014-0545-6.
Erectile dysfunction (ED) is highly prevalent affecting at least 50 % of men with diabetes mellitus (DM). DM may cause ED through a number of pathophysiological pathways. These include neuropathy, endothelial dysfunction, cavernosal smooth muscle structural/functional changes, and hormonal changes.
PMID 25193347

Treatment satisfaction with tadalafil or tamsulosin vs placebo in men with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH): results from a randomised, placebo-controlled study.

Oelke M1, Giuliano F, Baygani SK, Melby T, Sontag A.
BJU international.BJU Int.2014 Oct;114(4):568-75. doi: 10.1111/bju.12733.
OBJECTIVES: To assess treatment satisfaction with tadalafil or tamsulosin vs placebo in a 12-week, randomised, double-blind study of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH).PATIENTS AND METHODS: After a 4-week placebo lead-in period, men aged ≥45
PMID 24612148

Japanese Journal

Inhibition of Phosphodiesterase Type 3 Dilates the Rat Ductus Arteriosus Without Inducing Intimal Thickening

ICHIKAWA Yasuhiro,YOKOYAMA Utako,IWAMOTO Mari,OSHIKAWA Jin,OKUMURA Satoshi,SATO Motohiko,YOKOTA Shumpei,MASUDA Munetaka,ASOU Toshihide,ISHIKAWA Yoshihiro
Circulation journal : official journal of the Japanese Circulation Society 76(10), 2456-2464, 2012-09-25
… The purpose of this study was therefore to investigate potential DA dilators, such as phosphodiesterase 3 (PDE3) inhibitors, as alternatives to PGE1. … Conclusions: Because PDE3 inhibitors induced longer-lasting vasodilation without causing apnea or HA-mediated IT, they may be good alternatives to PGE1 for patients with DA-dependent CHD. …
NAID 10030875150

Pulmonary hypertension associated with veno-occlusive disease in systemic sclerosis: Insight into the mechanism of resistance to vasodilator

Tada Hayato,Konno Tetsuo,Aizu Motohiko,Yokawa Junichiro,Tsubokawa Toshinari,Fujii Hiroshi,Hayashi Kenshi,Uchiyama Katsuharu,Matsumura Masami,Kawano Mitsuhiro,Kawashiri Masa-aki,Yamagishi Masakazu
Journal of Cardiology Cases 5(1), e44-e47, 2012-02-00
… Several aggressive treatments with pulmonary vasodilators, including oral prostaglandin, endothelin receptor antagonists, and phosphodiesterase 5 inhibitors, failed to improve her symptoms. … We suggest that prevalence of veno-occlusive type of disease could be one of the major mechanisms of less responsive or even refractory to pulmonary vasodilator therapies in patients with PAH associated with connective tissue disease. …
NAID 120003959455

Related Pictures

Phosphodiesterase Type 5 | Circulation Research 10 Natural PDE5 Inhibitors: Powerful Natural Viagra Alternatives That Work What are oral therapies for ED— specifically, the phosphodiesterase type 5 (PDE-5 Evidence for Pleiotropic Effects of Phosphodiesterase-5 (PDE5) Inhibitors: Emerging phosphodiesterase type 5 (PDE5) inhibitor « New Drug Approvals Phosphodiesterase Type 5 | Circulation Research Potential Therapeutic Role of Phosphodiesterase Type 5 Inhibition in Hypertension and